Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Progress in therapies for cystic fibrosis.Lancet Respir Med. 2016; 4: 662-674
- Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.PLoS Genet. 2018; 14: e1007723
- Prevalence of CBAVD in azoospermic men carrying pathogenic CFTR mutations - evaluated in a cohort of 639 non-vasectomized azoospermic men.Andrology. 2021; 9: 588-598
- Functional assays are essential for interpretation of missense variants associated with variable expressivity.Am J Hum Genet. 2018; 102: 1062-1077
- Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.JCI Insight. 2018; 3: 121159
- Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis.Am J Respir Crit Care Med. 2019; 199: 1116-1126
- The influence of CFTR complex alleles on precision therapy of cystic fibrosis.J Cyst Fibros. 2020; 19: S15-S18
- Genetic Modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits.J Clin Endocrinol Metab. 2020; 105: dgz102
- Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity.J Cyst Fibros. 2020; 19: S10-S14
- Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).J Cyst Fibros. 2021; 20: 810-819
- mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.Clin Genet. 2017; 91: 476-481
- Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele.N Engl J Med. 2019; 381: 1809-1819
- Discovery of CFTR modulators for the treatment of cystic fibrosis.Expert Opin Drug Discov. 2021; 16: 897-913
- Amplifiers co-translationally enhance CFTR biosynthesis via PCBP1-mediated regulation of CFTR mRNA.J Cyst Fibros. 2020; 19: 733-741
- Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.PLoS Genet. 2020; 16: e1009100
- Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.Nucleic Acids Res. 2020; 48: 7454-7467
- Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation.J Cyst Fibros. 2021; 20: 865-875
- Correction of a cystic fibrosis splicing mutation by antisense oligonucleotides.Hum Mutat. 2016; 37: 209-215
- Rescue of common exon-skipping mutations in cystic fibrosis with modified U1 snRNAs.Hum Mutat. 2020; 41: 2143-2154
- A deep learning approach to identify gene targets of a therapeutic for human splicing disorders.Nat Commun. 2021; 12: 3332
- Mechanism-based personalized medicine for cystic fibrosis by suppressing pseudo exon inclusion.Cell Chem Biol. 2020; 27: 1472-1482.e6
- How to get away with nonsense: mechanisms and consequences of escape from nonsense-mediated RNA decay.Wiley Interdiscip Rev RNA. 2020; 11: e1560
- Nonsense-mediated RNA decay pathway inhibition restores expression and function of W1282X CFTR.Am J Respir Cell Mol Biol. 2019; 61: 290-300
- Decreased mRNA and protein stability of W1282X limits response to modulator therapy.J Cyst Fibros. 2019; 18: 606-613
- The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.Hum Mutat. 2019; 40: 326-334
- Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.eLife. 2020; 9: e52611
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.Lancet Respir Med. 2014; 2: 539-547
- Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids.J Cyst Fibros. 2021; 20: 436-442
- A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.Nat Commun. 2021; 12: 4358
- New therapeutic approaches to mendelian disorders.N Engl J Med. 2010; 363: 852-863
- Pseudouridine-mediated stop codon readthrough in S. cerevisiae is sequence context–independent.RNA. 2020; 26: 1247-1256
- Therapeutic promise of engineered nonsense suppressor tRNAs.Wiley Interdiscip Rev RNA. 2021; 12: e1641
- Engineered transfer RNAs for suppression of premature termination codons.Nat Commun. 2019; 10: 822
- Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis.ERJ Open Res. 2020; 6: 00429-02020
- TMEM16A potentiation: a novel therapeutic approach for the treatment of cystic fibrosis.Am J Respir Crit Care Med. 2020; 201: 946-954
- Cystic fibrosis gene therapy: looking back, looking forward.Genes. 2018; 9: E538
- Optimization of recombinant adeno-associated virus-mediated expression for large transgenes, using a synthetic promoter and tandem array enhancers.Hum Gene Ther. 2015; 26: 334-346
- Lipid nanoparticle-delivered chemically modified mRNA restores chloride secretion in cystic fibrosis.Mol Ther J Am Soc Gene Ther. 2018; 26: 2034-2046
- Viral vectors, animal models, and cellular targets for gene therapy of cystic fibrosis lung disease.Hum Gene Ther. 2020; 31: 524-537
- Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus.Mol Ther J Am Soc Gene Ther. 2021; https://doi.org/10.1016/j.ymthe.2021.03.023
- Targeted integration of a super-exon into the CFTR locus leads to functional correction of a cystic fibrosis cell line model.PLoS One. 2016; 11: e0161072
- Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium.Nat Commun. 2015; 6: 6952
- Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.Nat Commun. 2019; 10: 3556
- Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.PLoS One. 2017; 12: e0184009
- High-Efficiency, selection-free gene repair in airway stem cells from cystic fibrosis patients rescues CFTR function in differentiated epithelia.Cell Stem Cell. 2020; 26: 161-171.e4
- Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.J Cyst Fibros. 2021; https://doi.org/10.1016/j.jcf.2021.05.014
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature. 2016; 533: 420-424
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.Nature. 2017; 551: 464-471
- Functional correction of CFTR mutations in human airway epithelial cells using adenine base.Nucleic Acids Res. 2021; : gkab788https://doi.org/10.1093/nar/gkab788
- CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank.Cell Stem Cell. 2020; 26: 503-510.e7
- Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope.Nat Commun. 2020; 11: 1979
- Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning.Nat Biotechnol. 2021; https://doi.org/10.1038/s41587-021-00938-z
- Search-and-replace genome editing without double-strand breaks or donor DNA.Nature. 2019; 576: 149-157
- Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.Life Sci Alliance. 2021; 4: e202000940https://doi.org/10.26508/lsa.202000940
Article info
Footnotes
The authors have nothing to disclose.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
